- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Surgeon General Nominee; Patient Assistance Charity; Medicaid Under Senate Bill
Trump Administration Nominates New Surgeon General
Indiana health commissioner Jerome Adams, MD, has been nominated to be the country’s next surgeon general. STAT reported that Vice President Mike Pence appointed Adams to his current role when Pence was still governor. Adams would replace former Surgeon General Vivek Murthy, MD, who was pushed out by the Trump administration in April. Similar to Murthy, Adams has been an advocate for addressing the opioid epidemic.
Investigation Into Patient Assistance Charity
The IRS is investigating whether a patient-assistance charity improperly benefited pharmaceutical companies. The probe is trying to determine whether the charity Good Days returned most of the money pharmaceutical companies donated as payments for their drugs, according to Reuters. Good Days operates a copay assistance program and the IRS claims that in 2011 about 95% of the assistance provided to patients was spent on drugs made by companies that had made donations.
CBO Releases Addendum to Initial Senate Health Bill Report
An addendum from the Congressional Budget Office released Thursday detailed the impact of the Senate health bill on Medicaid over 2 decades. The addendum to the initial analysis was released at the request of Democratic senators who wanted to see an estimate past the 10-year window typically provided. The CBO found that in the first 10 years, Medicaid funding would decrease 26%, and by the end of the second decade, Medicaid spending would be 35% lower.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
